Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research at Helmholtz Munich; honors patient families
Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research at Helmholtz Munich; honors patient families Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research The CureGPX4 Foundation has named Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, as the first recipient of the Raghav Prize for Rare Disease and Citizen Science. The prize recognizes his research into a structural feature of the GPX4 enzyme that is essential for protecting nerve cells, as well as the close involvement of affected families in the project. ...